טוען...
Novel CD123 polyaptamer hydrogel edited by Cas9/sgRNA for AML-targeted therapy
CD123 targeting molecules have been widely applied in acute myelocytic leukemia (AML) therapeutics. Although antibodies have been more widely used as targeting molecules, aptamer have unique advantages for CD123 targeting therapy. In this study, we constructed an aptamer hydrogel termed as SSFH whic...
שמור ב:
| הוצא לאור ב: | Drug Deliv |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Taylor & Francis
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8205012/ https://ncbi.nlm.nih.gov/pubmed/34121564 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2021.1934191 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|